(Q43228809)

16 November 2017

title

Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial (English)

1 reference

16 November 2017

1 reference

1

Soumya Swaminathan

0 references

author name string

Gopalan Narendran

2

1 reference

16 November 2017

Perumal Venkatesan

3

1 reference

16 November 2017

Sheik Iliayas

4

1 reference

16 November 2017

Rameshkumar Santhanakrishnan

5

1 reference

16 November 2017

Pradeep Aravindan Menon

6

1 reference

16 November 2017

Chandrasekharan Padmapriyadarsini

7

1 reference

16 November 2017

Ranjani Ramachandran

8

1 reference

16 November 2017

Ponnuraja Chinnaiyan

9

1 reference

16 November 2017

Mohanarani Suhadev

10

1 reference

16 November 2017

Raja Sakthivel

11

1 reference

16 November 2017

Paranji R Narayanan

12

1 reference

16 November 2017

language of work or name

English

0 references

publication date

3 December 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

16 November 2017

published in

1 reference

16 November 2017

volume

181

1 reference

16 November 2017

issue

7

1 reference

16 November 2017

page(s)

743-751

1 reference

Natural history of human immunodeficiency virus disease in southern India

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Treatment Options for HIV-Associated Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

A NEW AND RAPID METHOD FOR THE ISOLATION AND CULTIVATION OF TUBERCLE BACILLI DIRECTLY FROM THE SPUTUM AND FECES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Treatment outcomes of patients with HIV and tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0439OC

10.1164/RCCM.200903-0439OC

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference